Skip to main content

Adoptive Cell Therapies (ACT) & CAR T Cell

With over 80 unique hematological malignancy cell lines, such as the CD19+ Raji-Luc lymphoma model, the MV-411-Luc leukemia model, and the MM.1S-Luc multiple myeloma model, we lead the industry with market-relevant models for your studies. We also have an ever-expanding list of solid tumor models validated in NSG mice to support the field’s drive toward approval of an adoptive cell therapy (ACT) in a solid tumor indication.

Discover an unparalleled breadth of experience in the use of mouse tumor models to evaluate adoptive cell therapies (ACTs).

With a broad range of disseminated and subcutaneous tumor models characterized in NSG mice, and a scientific team that knows how to apply them, we can guide selection of the right tumor model for your CAR T cell or other ACT study.

Tumor Models by Histotype, Targeted with Adoptive Cell Therapy: Hematological Malignancies

Leukemia [AML]
HumanMouse

EOL-1
Kasumi-1
Kasumi-3
Kasumi-3-Luc-mCh-Puro
KG-1-Luc-mCh-Puro
MOLM-13
MV-4-11
MV-4-11-FUW-Luc-mCh-Puro
NOMO-1
THP-1

C1498
C1498-Luc-mCh-Puro

Leukemia [B-ALL]
Human
NALM6
NALM6-Luc-MCh-Puro
Reh
Reh (pMMP-Luc-Neo)
RS4;11
Lymphoma [B-Cell]
HumanMouse
DB
DB/M2
A20
A20-Luc2-Puro
Lymphoma [B-NHL]
Human
Farage
GRANTA-519
Lymphoma [Burkitt’s]
Human
B-JAB
Daudi
Daudi-Luc-mCh-Puro
NAMALWA
Raji
Raji-Luc
Ramos
Ramos-Luc
Lymphoma [DLBCL]
Human
OCI-Ly1 LN
OCI-Ly19-Luc-Neo
OCI-Ly3-Luc-mCh-Puro
OCI-Ly7-Luc-mCh-Puro (rescued)
OCI-Ly7-Luc-Neo
Pfeiffer
SU-DHL-10
SU-DHL-10-LN-High
SU-DHL-16
SU-DHL-4-Luc-mCh-Puro
SU-DHL-8
TMD8
Toledo-Luc-Neo
WSU-DLCL2

Myeloma
HumanMouse
JJN-3-Luc
MM.1S (pMMP-Luc-Neo)
NCI-H929
NCI-H929-Luc-mCh-Puro
OPM-2
RPMI 8226
U266B1
5TGM1-Luc
J558

Tumor Models by Histotype, Targeted with Adoptive Cell Therapy: Solid Tumors

Brain
HumanMouse
BT142
D54-Luc
DBTRG (tumor)
DBTRG-05MG
Gli36-DsRed-R-Luc (rescued)
LN-18
LN-229
LN-827(pMMP-LucNeo)
M059K
SF-295
SF-539
SF-767
SNB-19
U-87 MG
U-87 MG-Luc
U251
U251-Luc-mCh-Puro
GL261
GL261-Luc2

Liver
HumanMouse
Hep 3B2.1-7
Hep G2
BNL 1ME A.7R.1
BNL 1ME A.7R.1-Luc-mCh-Puro
Hep55.1c
Hepa 1-6
Hepa 1-6-Luc-mCh-Puro

Lung
Mouse
LL
LL/2
LL/2-Luc-M38
Lung [Adenosquamous]
Human
NCI-H596
Lung [Anaplastic Carcinoma]
Human
Calu-6
Lung [Bronchioalveolar]
Human
NCI-H322M
Lung [NSCLC]
Human
A549
A549-Luc-C8
Calu-1
Calu-3
HCC827
HCC827-Luc-mCh-Puro
NCI-H125
NCI-H125-Luc
NCI-H1299
NCI-H1650
NCI-H1703
NCI-H1703-Luc-mCh-Puro
NCI-H1975
NCI-H1975-Luc
NCI-H2110
NCI-H2122
NCI-H23
NCI-H292
NCI-H3122
NCI-H441
NCI-H460
NCI-H460-Luc2
NCI-H522
PC-9
Lung [SCLC]
Human
DMS 114
NCI-H446
NCI-H69
NCI-H82
SHP-77
Lung [Squamous]
Human
EBC-1
SK-MES-1

Mammary/Breast
HumanMouse
BT-20
BT-474
HCC70
Hs 578Bst
Hs 578T
MCF 10A
MCF-7
MCF7-Luc-mCh-Puro
MDA-MB-231
MDA-MB-231-2LMP
MDA-MB-231-Luc-D3H1
MDA-MB-231-Luc-D3H2
MDA-MB-231-Luc-D3H2LN
MDA-MB-231-Luc-D3H3
MDA-MB-361
MDA-MB-453
MDA-MB-468
MX-1-Luc
SK-BR-3
T47D
UISO-BCA-1
ZR-75-1
4T1-luc2
E0771
EMT-6
MMTV-PyMT

Ovarian
HumanMouse
A2780
A2780-Luc
IGROV1
IGROV1-Luc-Mch-Puro
NIH:OVCAR-3
NIH:OVCAR-3-Luc-mCh-Puro
OV-90
OVCAR-4
OVCAR-5
OVCAR-5-Luc-mCh-Puro
OVCAR-8
OVCAR-8-Luc-mCh-Puro
SK-OV-3
SKOV-3-luc-D3
ID8
ID8-Luc-mCh-Puro

Prostate
Human
22Rv1
CWR-22-R
DU 145
DU 145-Luc
LnCap clone FGC
PC-3
PC-3-Luc
PC-3M-Luc-C6
VCaP